<i>PTEN</i> genomic deletion is an early event associated with <i>ERG</i> gene rearrangements in prostate cancer
Tarek A. Bismar(University of Calgary), Jeremy A. Squire(Universidade de São Paulo), Matthew Firszt(McGill University), Maisa Yoshimoto(University of Alberta), Robin T. Vollmer(Duke Medical Center), Jacques Corcos(Jewish General Hospital), Qiuli Duan
Cited by 117
Related Papers
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
|British Journal of Cancer|2007|294
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
|Modern Pathology|2008|278
<i>PTEN</i> genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
|The Journal of Pathology|2009|210
Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery
|Cancer Epidemiology Biomarkers & Prevention|2008|209